• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19, An Issue of the Clinics in Laboratory Medicine

Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19, An Issue of the Clinics in Laboratory Medicine

9780323835862
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
398,11 zł
338,39 zł Zniżka 59,72 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 338,39 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In this issue of Clinics in Laboratory Medicine, guest editors Drs. Daimon P. Simmons and Peter H. Schur bring their considerable expertise to the topic of Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19. Top experts in the field cover key topics such as performance of central lab assays to detect SARS-COV-2 antibodies; alternative methods to detect SARS-CoV-2 antibodies; the role of antibodies in developing vaccines for COVID-19; SARS-COV-2 antibodies after immunization; and more.
Szczegóły produktu
Elsevier
92798
9780323835862
9780323835862

Opis

Rok wydania
2022
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Waga (g)
390
  • Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing - A Laboratory Primer
    Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review
    Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology
    Alternative Methods to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies
    Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation
    Antibody Dynamics and Durability in Coronavirus Disease-19
    Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses
    Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)
Komentarze (0)